The global pharmaceutical CDMO Aesica Pharmaceuticals has launched its new brand identity in order to reflect the new alignment and consolidation of the full Consort Medical group following acquisition. The new logo and branding will be adopted across all Consort Medical businesses, creating a consistent identity for all group companies. The combination of Aesica and Bespak will provide customers with a single source for drug and device development, formulation, manufacturing and packaging. Aesica provides API and finished dose formulation development and manufacturing services. Bespak is a global market leader in the development and manufacture of drug delivery devices